Endocrine Pharmaceuticals Overview
- Year Founded
-
1995
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Angel
- Latest Deal Amount
-
$33.3K
- Investors
-
1
Endocrine Pharmaceuticals General Information
Description
Provider of therapeutic research services intended to specialize in the hormonal regulation of tissue mass and integrity. The company's services help in the treatment of benign and malignant tissue overgrowth conditions affecting the pituitary, prostate, breast, heart, and kidneys, enabling healthcare providers to cure their patients of tumor growth and improve their lives.
Contact Information
Website
www.endopharm.co.ukCorporate Office
- Wilderness End
- Tadley Common Road
- Tadley RG26 3TA
- England, United Kingdom
Corporate Office
- Wilderness End
- Tadley Common Road
- Tadley RG26 3TA
- England, United Kingdom
Endocrine Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Angel (individual) | 05-Jan-2022 | $33.3K | Completed | Generating Revenue | ||
| 4. Secondary Transaction - Private | 01-Apr-2021 | Completed | Pre-Clinical Trials | |||
| 3. Later Stage VC | 31-Dec-2019 | Completed | Pre-Clinical Trials | |||
| 2. Grant | 01-Aug-2017 | Completed | Startup | |||
| 1. Later Stage VC | 01-Nov-2013 | Completed | Startup |
Endocrine Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Endocrine Pharmaceuticals Patents
Endocrine Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202112385-D0 | Hormonal derivatives | Pending | 31-Aug-2021 | ||
| GB-2610229-A | Hormonal derivatives | Pending | 31-Aug-2021 | ||
| GB-0800502-D0 | Peptides and their uses | Inactive | 11-Jan-2008 | ||
| GB-0800373-D0 | A peptide | Inactive | 10-Jan-2008 | ||
| EP-2234632-A2 | Proteinaceous compounds | Active | 10-Jan-2008 | C07K14/4702 |
Endocrine Pharmaceuticals Signals
Endocrine Pharmaceuticals Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Government of UK | Government |
Endocrine Pharmaceuticals FAQs
-
When was Endocrine Pharmaceuticals founded?
Endocrine Pharmaceuticals was founded in 1995.
-
Where is Endocrine Pharmaceuticals headquartered?
Endocrine Pharmaceuticals is headquartered in Tadley, United Kingdom.
-
What is the size of Endocrine Pharmaceuticals?
Endocrine Pharmaceuticals has 3 total employees.
-
What industry is Endocrine Pharmaceuticals in?
Endocrine Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Endocrine Pharmaceuticals a private or public company?
Endocrine Pharmaceuticals is a Private company.
-
What is the current valuation of Endocrine Pharmaceuticals?
The current valuation of Endocrine Pharmaceuticals is .
-
What is Endocrine Pharmaceuticals’s current revenue?
The current revenue for Endocrine Pharmaceuticals is .
-
How much funding has Endocrine Pharmaceuticals raised over time?
Endocrine Pharmaceuticals has raised $33.3K.
-
Who are Endocrine Pharmaceuticals’s investors?
Government of UK has invested in Endocrine Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process